BioCryst Reports Fourth Quarter and Full Year 2021 Financial Results and Upcoming Key Milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/14/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to BioCryst Reports Fourth Quarter and Full Year 2021 Financial Results and Upcoming Key Milestones

BioCryst Pharma (BCRX) Reports Q4 Loss of $0.40/sh

February 23, 2022 7:39 AM EST

BioCryst Pharma (NASDAQ: BCRX) reported Q4 EPS of ($0.40), versus ($0.34) reported last year. Revenue for the quarter came in at $47.2 million, versus $4 million reported last year.

For earnings history and earnings-related data on BioCryst Pharma (BCRX) click here.

... More